Cassava Sciences earnings miss, Revenue Inline in Q3

  • Investing.com
Cassava Sciences earnings miss, Revenue Inline in Q3

Investing.com - Cassava Sciences reported on Monday third quarter earnings that missed analysts' forecasts and revenue that was inline with expectations.

Cassava Sciences announced earnings per share of $-0.51 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.43 on revenue of $0.00.

Cassava Sciences shares are down 57% from the beginning of the year and are trading at $36.15 , down-from-52-week-high.

Cassava Sciences shares gained 2.50% in intra-day trade the report.

Cassava Sciences follows other major Healthcare sector earnings this month

Cassava Sciences's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.

J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles